These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20122977)

  • 1. A stochastic whole-body physiologically based pharmacokinetic model to assess the impact of inter-individual variability on tissue dosimetry over the human lifespan.
    Beaudouin R; Micallef S; Brochot C
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):103-16. PubMed ID: 20122977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry.
    Clewell HJ; Gentry PR; Covington TR; Sarangapani R; Teeguarden JG
    Toxicol Sci; 2004 Jun; 79(2):381-93. PubMed ID: 15056818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicokinetic modeling and its applications in chemical risk assessment.
    Andersen ME
    Toxicol Lett; 2003 Feb; 138(1-2):9-27. PubMed ID: 12559690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment.
    Troutman JA; Rick DL; Stuard SB; Fisher J; Bartels MJ
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):530-43. PubMed ID: 26188115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically-based pharmacokinetic (PBPK) models for assessing the kinetics of xenobiotics during pregnancy: achievements and shortcomings.
    Lu G; Abduljalil K; Jamei M; Johnson TN; Soltani H; Rostami-Hodjegan A
    Curr Drug Metab; 2012 Jul; 13(6):695-720. PubMed ID: 22452453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the use of a physiologically based pharmacokinetic model and a classical pharmacokinetic model for dioxin exposure assessments.
    Emond C; Michalek JE; Birnbaum LS; DeVito MJ
    Environ Health Perspect; 2005 Dec; 113(12):1666-8. PubMed ID: 16330344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of a physiologically-based pharmacokinetic model using the distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the tissues of the eastern oyster (Crassostrea virginica).
    Wintermyer M; Skaidas A; Roy A; Yang YC; Georgapoulos P; Burger J; Cooper K
    Mar Environ Res; 2005 Aug; 60(2):133-52. PubMed ID: 15757746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.
    Andersen ME
    Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Pharmacokinetics.
    Bois FY; Brochot C
    Methods Mol Biol; 2016; 1425():37-62. PubMed ID: 27311461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.
    Abduljalil K; Furness P; Johnson TN; Rostami-Hodjegan A; Soltani H
    Clin Pharmacokinet; 2012 Jun; 51(6):365-96. PubMed ID: 22515555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
    Fenneteau F; Poulin P; Nekka F
    J Pharm Sci; 2010 Jan; 99(1):486-514. PubMed ID: 19479982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat.
    Emond C; Birnbaum LS; DeVito MJ
    Toxicol Sci; 2004 Jul; 80(1):115-33. PubMed ID: 15056810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models.
    Krewski D; Wang Y; Bartlett S; Krishnan K
    J Biopharm Stat; 1995 Nov; 5(3):245-71. PubMed ID: 8580927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry.
    Clewell HJ; Teeguarden J; McDonald T; Sarangapani R; Lawrence G; Covington T; Gentry R; Shipp A
    Crit Rev Toxicol; 2002 Sep; 32(5):329-89. PubMed ID: 12389868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats.
    Wang X; Santostefano MJ; Evans MV; Richardson VM; Diliberto JJ; Birnbaum LS
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):151-68. PubMed ID: 9356318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible range of dioxin concentration in human tissues: simulation with a physiologically based model.
    Maruyama W; Yoshida K; Tanaka T; Nakanishi J
    J Toxicol Environ Health A; 2002 Dec; 65(24):2053-73. PubMed ID: 12515586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.
    Thompson CM; Johns DO; Sonawane B; Barton HA; Hattis D; Tardif R; Krishnan K
    J Toxicol Environ Health B Crit Rev; 2009 Jan; 12(1):1-24. PubMed ID: 19117207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A.
    Yang X; Doerge DR; Teeguarden JG; Fisher JW
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):442-56. PubMed ID: 26522835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.